Statistics

Total Visits

Views
Phase II study of dovitinib in first line metastatic or (nonresectable primary) adrenocortical carcinoma (ACC): SOGUG study 2011-0363

Select a period of time:

Number of views in the range

Views
Phase II study of dovitinib in first line metastatic or (nonresectable primary) adrenocortical carcinoma (ACC): SOGUG study 2011-0310

Views

Views
November 20253
December 20250
January 20262
February 20260
March 20263
April 20260
May 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
Egypt2
United States2
Brazil2
Ecuador1
Morocco1
Ukraine1
Venezuela1
 

Top cities views

Views
Agadir1
Al Fayyum1
Al Mansurah1
Andaraí1
Dallas1
Las Golondrinas1
Maracaibo1
Pinheiro1
Simferopol1